Core Viewpoint - PetMed Express, Inc. has announced preliminary financial results for the fourth quarter and fiscal year 2025, indicating a significant decline in net sales and an increase in net loss compared to the previous year [1][2][3]. Financial Performance - For the fiscal fourth quarter ended March 31, 2025, net sales are estimated to be between $51.1 million and $53.1 million, down from $66.5 million in the prior year [2]. - The estimated net loss for the fourth quarter is between $9.9 million and $10.4 million, compared to a net loss of $5.0 million in the prior year [2]. - For the fiscal year ended March 31, 2025, net sales are estimated to range from $231.6 million to $233.6 million, a decrease from $281.1 million in the prior year [3]. - The estimated net loss for the fiscal year is between $4.5 million and $5.0 million, an improvement from a net loss of $7.5 million in the prior year [3]. - The net loss includes a tax expense impact of $6.4 million due to a valuation allowance on the Company's net deferred tax assets [2][3]. Cash Position - As of March 31, 2025, the Company reported $54.7 million in cash and no debt [4]. Filing Status - The Company has filed Form 12b-25 with the SEC, indicating it is unable to file its Annual Report on Form 10-K within the prescribed time period, but expects to do so by July 1, 2025 [1][5].

Company Overview - Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care [5] - The company's flagship offering, HealthTab™, aims to create the world's largest network of rapid testing devices in community pharmacies [5] Stock Options Announcement - The board of directors of Avricore has approved the granting of stock options for a total of 4,100,000 common shares at an exercise price of CAD $0.05 per share [1] - The options will vest quarterly starting from the date of grant and will expire 5 years from the grant date, contingent on the optionees remaining in their roles [2] HealthTab™ Product Details - HealthTab™ is a point-of-care testing solution that provides lab-accurate results from just a few drops of blood, with real-time data reporting [3] - The test menu includes up to 23 key biomarkers for chronic disease management, including diabetes and heart disease, and has recently added capabilities for bacterial and viral tests [3] HealthTab™ Network Model - The HealthTab™ network model enhances the role of pharmacists in primary care delivery and empowers patients to take control of their health [4] - It aims to reduce costs and waiting times while providing multiple revenue streams, including equipment leasing, direct access testing, and decentralized clinical trials [4]

Core Insights - Amazon is restructuring its health business into six new units to simplify operations and enhance innovation [2][4][13] - The reorganization follows the departure of several senior health leaders, indicating potential challenges in leadership stability [5][6] - Amazon's long-term strategy in the healthcare sector remains ambitious, aiming to penetrate the complex U.S. healthcare market [8][10] Company Developments - Amazon Health Services will now operate under six groups, each led by experienced executives from within the company and One Medical [3][16] - The company has not conducted broad layoffs during this restructuring process, focusing instead on internal talent [4] - Despite recent leadership changes, Amazon maintains confidence in its organizational talent and growth potential [13] Market Position and Strategy - Amazon's entry into the healthcare market began with the acquisition of PillPack for approximately $750 million in 2018, followed by the purchase of One Medical for $3.9 billion in 2023 [8][9] - The company has faced setbacks, including the closure of its telehealth service, Amazon Care, and the disbandment of the Haven venture [10][12] - Amazon's pharmacy business has reportedly doubled its customer base in the past year, with plans to expand into 20 new cities [15] Financial Performance - One Medical reported a net loss of $101.1 million on revenue of $272.4 million in its last quarter as an independent entity [14] - Amazon has not disclosed specific financial figures for its health business but claims to be experiencing strong growth across its offerings [13]

Key Takeaways Four GARP stocks, FLEX, CVS, URBN, and EXEL, were selected using a screen focused on PEG and value scores. Each pick has a PEG ratio below industry median, solid earnings outlook and a Zacks Rank of #1 or #2. FLEX leads with a 35.1% historical growth rate, while EXEL boasts 21.2% expected long-term earnings growth.In the equity market, investments always need to be prudently hedged to overcome uncertainties and limit losses related to external shocks. A question that often arises is whether ...

BrightSpring Health Services (BTSG) FY 2025 Conference June 11, 2025 02:40 PM ET Speaker0 Wanted to start, you just joined as CFO. You've been with the company a long time, but just as you get to know the investor community, just wanted to give you a chance to talk about your background and what you bring to the CFO seat that's new and helps the strategy of the company going forward. Speaker1 Sure. Thank you. I've been with the company for over eight and a half years, have been a part of everything that we' ...

As the June 18 deadline for bidding on the remaining assets of Rite Aid nears, the potential buyers who are looking them over reportedly include pharmacy chain Walgreens, reality star turned entrepreneur Kourtney Kardashian, consumer-focused private equity firms, and three brand management companies: Authentic Brands Group, WHP Global and Marquee Brands.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, i ...

Core Insights - Rite Aid is undergoing bankruptcy proceedings, with various companies, including Walgreens and brand management firms, evaluating its remaining assets [1][4][9] - Kourtney Kardashian has shown interest in acquiring Rite Aid's Thrifty ice cream brand, which has a history dating back to 1940 [3][7] Group 1: Bankruptcy and Asset Evaluation - Rite Aid operates approximately 1,200 stores and serves around 8 million customers, having filed for bankruptcy for the second time in two years [4][8] - The bankruptcy judge has approved store closures and the sale of customer prescription files to 13 buyers, including CVS Health and Walgreens [4][10] - Brand management companies such as Authentic Brands Group, WHP Global, and Marquee Brands are assessing Rite Aid's intellectual property and loyalty program [1][2] Group 2: Interest in Thrifty Ice Cream Brand - Kourtney Kardashian, co-founder of Lemme and owner of Poosh, is interested in Rite Aid's Thrifty ice cream brand, which is sold at various retailers [3][5][6] - Thrifty ice cream has a notable history and has attracted interest from consumer-focused private equity firms as well [7]

Key Takeaways CVS Health has been investing $20 billion over a decade to digitize and modernize its healthcare offerings. The new CVS Health app streamlines care access with AI search and cross-channel prescription tools. CVS shares have climbed 41.7% YTD, sharply beating the industry's negative performance.Retail pharmacy powerhouse, CVS Health (CVS) , is advancing its digital-first strategy and investing in emerging technologies as part of its long-term growth plan. The company recently announced plans ...

VANCOUVER, British Columbia, June 05, 2025 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or "Avricore") is pleased to report the appointment of Rodger Seccombe as CEO of the Company. Mr. Seccombe currently serves as Chief Technology Officer of Avricore and is the President and Co-Founder of its wholly owned subsidiary, HealthTab™ Inc. David Hall, Chairman of the board stated, "In his role as Avricore's CTO Rodger has been instrumental in the development of the Company's flagship Healt ...

Core Insights - Amazon Pharmacy is launching new features aimed at attracting seniors covered by Medicare's drug benefit, a market currently dominated by CVS Health and Walgreens [2][4] - The new "caregiver support feature" allows customers to have someone else manage their medications, enhancing convenience for those caring for elderly family members [3][8] - Customers with Medicare Part D can access PillPack, which simplifies medication management through pre-sorted and labeled packets delivered to their homes [4][6] Market Context - The U.S. prescription market is largely controlled by CVS and Walgreens, which together hold a 40% market share, while Amazon's share is less than 1% [6] - CVS filled 435 million prescriptions in Q1, a 4.3% increase year-over-year, while Walgreens filled over 309 million prescriptions, up 3.4% [5] - Combined, CVS and Walgreens generated over $370 billion in prescription revenues last year [5] Demographic Trends - The Medicare prescription market is expanding, with over 11,000 Americans turning 65 every day, indicating a growing customer base for Amazon Pharmacy [6] - More than 50 million Americans are currently caring for an aging family member, presenting a significant opportunity for Amazon to cater to this demographic [7]